Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - NET INCOME
Net Income ANVS - Annovis Bio, Inc.
-56.2 M
LAST VALUE
-96.97%
2 YEAR CAGR
-139.46%
5 YEAR CAGR
0.00%
10 YEAR CAGR